Last reviewed · How we verify

NCT06696677

Small Intestine Length Measurement Using 3D CT Volumetry and in Vivo Measurement Using Pre-marked Graspers in Revisional Bariatric Surgeries. A Comparative Study

Recruiting now NA Last updated 28 January 2025
What this trial tests

NA trial testing CT in Small Intestine Length in 30 participants. Currently enrolling.

Timeline
26 January 2025
Primary endpoint
30 July 2025
31 July 2025

Quick facts

Lead sponsorKasr El Aini Hospital
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationnon randomized
Designsingle group
Maskingsingle
Primary purposediagnostic
Enrollment30
Start date26 January 2025
Primary completion30 July 2025
Estimated completion31 July 2025
Sites2 locations across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Kasr El Aini Hospital

Who can join

Adults 16 to 70, any sex, with Small Intestine Length. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Measuring bowel length during hypo-absorptive surgeries like Roux-en-Y gastric bypass (RYGB) and Single Anastomosis Duodeno-ileal Sleeve (SADI-s) is controversial and usually abandoned due to the high risk of intestinal injury. However, some surgeons, especially in revisional surgery, prefer to count the whole bowel length to avoid leaving very short segments and severe malnutrition afterwards. 3D reconstructed CT scan can be useful in such conditions, avoiding the risk of intestinal injury, but accurate measures might be doubtful.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of CT

Trials testing the same drug.

Other Kasr El Aini Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06696677.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing